Literature DB >> 21252242

Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.

Edmond P Wickham1, Kathryn G Ewens, Richard S Legro, Andrea Dunaif, John E Nestler, Jerome F Strauss.   

Abstract

CONTEXT: Single-nucleotide polymorphisms (SNPs) in the SHBG gene are associated with type 2 diabetes mellitus. SHBG has also been proposed as a candidate gene for the polycystic ovary syndrome (PCOS).
OBJECTIVE: The study aims were 1) to determine whether any of four SHBG SNPs (rs1779941, rs6297, rs6259, and rs727428) are associated with PCOS and 2) to determine whether SNP genotype influences SHBG levels in PCOS women.
DESIGN: Using the transmission disequilibrium test, evidence of associations between SHBG SNPs and PCOS were analyzed. Additionally, correlations between SHBG levels and SNP genotype, body mass index, non-SHBG-bound testosterone, and insulin resistance estimated by the homeostasis model were determined.
SETTING: The study was conducted at academic medical centers. PATIENTS OR OTHER PARTICIPANTS: A total of 430 families having a proband with PCOS were included in the family-based study. Associations between SNP genotypes, SHBG, and metabolic parameters were determined in 758 women with PCOS including probands from the family cohort. MAIN OUTCOME MEASURES: Primary outcome measures included transmission frequency of SNP alleles and correlation coefficients between SHBG and allele frequency/metabolic parameters.
RESULTS: No evidence of association between SNPs of interest and PCOS was found. However, in multivariate analyses, SHBG levels varied significantly with rs1799941 and rs727428 genotype after controlling for body mass index, non-SHBG-bound testosterone, and homeostasis model for insulin resistance.
CONCLUSIONS: Although SHBG SNPs associated with type 2 diabetes mellitus do not appear to be associated with PCOS status, rs1799941 and rs727428 genotypes are associated with SHBG levels independent of the effects of insulin resistance and obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252242      PMCID: PMC3070246          DOI: 10.1210/jc.2010-1842

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12----p13).

Authors:  D Bérubé; G E Séralini; R Gagné; G L Hammond
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; W Futterweit; A Dobrjansky
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

3.  The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

Authors:  A Dunaif; D Scott; D Finegood; B Quintana; R Whitcomb
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

4.  Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden.

Authors:  G Lindstedt; P A Lundberg; L Lapidus; H Lundgren; C Bengtsson; P Björntorp
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

5.  Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin.

Authors:  S R Plymate; L A Matej; R E Jones; K E Friedl
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

6.  Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line.

Authors:  S E Edmunds; A P Stubbs; A A Santos; M L Wilkinson
Journal:  J Steroid Biochem Mol Biol       Date:  1990-12-10       Impact factor: 4.292

7.  Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; D R Shelley; G Green; A Dobrjansky; T Licholai
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

8.  A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

Authors:  J E Nestler; L P Powers; D W Matt; K A Steingold; S R Plymate; R S Rittmaster; J N Clore; W G Blackard
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

9.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

Authors:  A H Carey; D Waterworth; K Patel; D White; J Little; P Novelli; S Franks; R Williamson
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

10.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

View more
  21 in total

1.  Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.

Authors:  Alice Albu; Serban Radian; Simona Fica; Carmen Gabriela Barbu
Journal:  Endocrine       Date:  2014-07-15       Impact factor: 3.633

2.  Association of rs6259 polymorphism with SHBG levels and Poly Cystic Ovary Syndrome in Indian population: a case control study.

Authors:  Richa Bhatnager; Alka Senwal; Smiti Nanda; Amita S Dang
Journal:  Mol Biol Rep       Date:  2019-02-04       Impact factor: 2.316

3.  Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.

Authors:  Guangfu Jin; Jielin Sun; Seong-Tae Kim; Junjie Feng; Zhong Wang; Sha Tao; Zhuo Chen; Lina Purcell; Shelly Smith; William B Isaacs; Roger S Rittmaster; S Lilly Zheng; Lynn D Condreay; Jianfeng Xu
Journal:  Hum Mol Genet       Date:  2012-08-30       Impact factor: 6.150

Review 4.  Sex hormone-binding globulin and type 2 diabetes mellitus.

Authors:  Trang N Le; John E Nestler; Jerome F Strauss; Edmond P Wickham
Journal:  Trends Endocrinol Metab       Date:  2011-11-01       Impact factor: 12.015

5.  Testosterone levels and the genetic variation of sex hormone-binding globulin gene of Bubalus bubalis, bulls in Egypt.

Authors:  Samy Naeem; Ahmed Ghoneim; Gamal Abd-Allah; Omaima Hassan
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

Review 6.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

7.  Evaluating reported candidate gene associations with polycystic ovary syndrome.

Authors:  Cindy Pau; Richa Saxena; Corrine Kolka Welt
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

Review 8.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

9.  Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.

Authors:  L J Moran; H J Teede; M Noakes; P M Clifton; R J Norman; G A Wittert
Journal:  J Endocrinol Invest       Date:  2013-07-01       Impact factor: 4.256

10.  Association between sex hormone binding globulin gene polymorphism and type 2 diabetes mellitus.

Authors:  Li Quan; Liang Wang; Jing Wang; Binya Yuwen; Jun Zhu
Journal:  Int J Clin Exp Pathol       Date:  2019-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.